MRC Clinical Trials Unit at UCL
2nd Floor
90 High Holborn
London
WC1V 6LJ
Email: mrcctu.stampede@ucl.ac.uk
Sites are expected to keep track of what samples have been collected for patients in the STAMPEDE sub studies. Please ensure to keep a copy of the saliva form, use the accountability log found in the Sample collection and handling manual or on the STAMPEDE website to help with sample tracking.
The only results reported back to patients will be those which have known medical implications and for which testing would be available under standard NHS genetic testing guidelines.
The results of this research analysis may not be available immediately and does not replace any genetic screening that your doctor may recommend as part of standard clinical care.
The only results reported back to patients will be those which have known medical implications and for which testing would be available under standard NHS genetic testing guidelines.
The results of this research analysis may not be available immediately and does not replace any genetic screening that your doctor may recommend as part of standard clinical care.
Every effort will be made to preserve tissue. We will return any usable tissue back to sites once our analysis is complete.
Refer to page 17 of the sample handling manual, available on the STAMPEDE website, where there is a table on how to check for appropriate consent.
Have another question or looking for more information? why not check out the STAMPEDE Training Suite for the training slides detailing information on STAMPEDE.
STAMPEDE
MRC Clinical Trials Unit at UCL
2nd Floor
90 High Holborn
London
WC1V 6LJ
Email: mrcctu.stampede@ucl.ac.uk
STAMPEDE
Systemic Therapy in Advancing or Metastatic Prostate cancer: Evaluation of Drug Efficacy
See the latest News in STAMPEDE through the link to the right.